Seeking SOCS and sex steroids

Trends in Endocrinology and Metabolism

Volumn 14, Issue 4, 2003, Pages 149-151

  Waters, Michael J ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; ESTROGEN; GROWTH HORMONE; INHIBITOR PROTEIN; JANUS KINASE; LEUKEMIA INHIBITORY FACTOR; SEX HORMONE; SOMATOMEDIN C; STAT PROTEIN;

GENE DELETION; GROWTH INHIBITION; HORMONE SUBSTITUTION; HUMAN; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION;

EID: 0038408522     PISSN: 10432760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1043-2760(03)00050-X     Document Type: Review

References (16)

1. Rossouw, J.E. et al. (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 288, 321-333
2. O'Sullivan, A.J. et al. (1998) The route of estrogen replacement therapy confers divergent effects on substrate oxidation and body composition in postmenopausal women. J. Clin. Invest. 102, 1035-1040
3. Wolthers, T. et al. (2001) Estrogen antagonizes the metabolic actions of GH in GH deficient women. Am. J. Physiol. Endocrinol. Metab. 281, E1191-E1196
4. Leung, K.C. et al. (2003) Estrogen inhibits GH signaling by suppressing GH-induced JAK2 phosphorylation, an effect mediated by SOCS-2. Proc. Natl. Acad. Sci. U. S. A. 100, 1016-1021
5. Nicola, N.A. and Greenhalgh, C.J. (2000) The SOCS proteins; important feedback inhibitors of cytokine action. Exp. Hematol. 28, 1105-1112
6. Colson, A. et al. (2000) Potentiation of GH-induced liver SOCS mRNA by cytokines. Endocrinology 141, 3687-3695
7. Metcalf, D. et al. (2000) Gigantism in mice lacking SOCS-2. Nature 405, 1069-1073
8. Horvat, S. and Medrano, J.F. (2001) Lack of SOCS 2 expression causes the high-growth phenotype in mice. Genomics 72, 209-212
9. Greenhalgh, C.J. et al. (2002) Growth enhancement in SOCS-2 deficient mice is dependent on STAT5b. Mol. Endocrinol. 16, 1394-1406
10. Barnard, N.D. et al. (2002) The current use of estrogens for growth-suppressant therapy in adolescent girls. J. Pediatr. Adolesc. Gynecol. 15, 23-26
11. Waters, M.J. (1999) In The Handbook of Physiology (Kostyo, J.L. and Goodman, H.M., eds) pp. 397-444, Oxford University Press
12. Stoecklin, E. et al. (1999) Interactions in the transcriptional regulation exerted by Stat5 and by members of the steroid hormone receptor family. J. Steroid Biochem. Mol. Biol. 69, 195-204
13. Turnley, A.M. et al. (2002) SOCS-2 regulates neuronal differentiation by inhibiting GH signaling, Nat. Neurosci. 5, 1155-1162
14. Morales, O. et al. (2002) 1α,25-dihydroxyvitamin D3 inhibits GH-induced expression of SOCS-3 and CIS and prolongs GH signaling via the JAK-STAT5 system in osteoblast-like cells. J. Biol. Chem. 277, 34879-34884
15. Curlewis, J.D. et al. (2002) A prostaglandin-F2α analogue induces SOCS-3 expression in the corpus luteum of the pregnant rat. A potential new mechanism for luteolysis. Endocrinology 143, 3984-3993
16. Tam, S-P. et al. (2001) Tissue-specific induction of SOCS gene expression by prolactin. Endocrinology 142, 5015-5026